Literature DB >> 27461628

Syk expression in non-small-cell lung cancer and its relation with angiogenesis.

Peng Chuanliang1, Zhao Yunpeng1, Hao Yingtao1, Sun Qifeng1, Zhao Xiaogang1, Cong Bo1.   

Abstract

OBJECTIVE: To study the expression of spleentyrosine kinase (Syk) gene in non--small--cell lung cancer and the relationship between Syk mRNA and microvessel density (MVD) in the tumor cells.
MATERIALS AND METHODS: The expression of Syk gene in 70 cases of lung tumor tissues, adjacent tissues, and normal lung tissues were examined with reverse transcription polymerase chain reaction (RT--PCR). The expression of MVD was examined with immunohistochemical streptavidin--biotin complex (SABC). The relation between them was analyzed.
RESULTS: Syk mRNA expression rates were 5.7, 95.7, and 100% in tumor, adjacent lung cells, and normal lung cells, respectively. The expression rate in tumor cells was significantly lower compared with those in normal lung tissue and adjacent lung tissue (P < 0.05), expression rate among different pathologic types, differentiation and clinical stages did not reveal any statistically significant differences (P > 0.05). The positive rate of CD34 in tumor was higher than that in adjacent tissues and normal lung tissues. The expression of Syk mRNA and MVD were negatively correlated.
CONCLUSIONS: The lack of Syk mRNA expression in lung cancer play an important role in angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27461628     DOI: 10.4103/0973-1482.154082

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  4 in total

1.  Novel genetic variants of SYK and ITGA1 related lymphangiogenesis signaling pathway predict non-small cell lung cancer survival.

Authors:  Lihua Liu; Hongliang Liu; Sheng Luo; Edward F Patz; Carolyn Glass; Li Su; Lijuan Lin; David C Christiani; Qingyi Wei
Journal:  Am J Cancer Res       Date:  2020-08-01       Impact factor: 6.166

2.  Expression of Syk and MAP4 proteins in ovarian cancer.

Authors:  Siwei Zhang; Suha Deen; Sarah J Storr; Anqi Yao; Stewart G Martin
Journal:  J Cancer Res Clin Oncol       Date:  2019-02-08       Impact factor: 4.553

3.  The Effect and Mechanism of Vascular Endothelial Growth Factor (VEGF) on Tumor Angiogenesis in Gallbladder Carcinoma.

Authors:  Dongqing Xu; Jianwen Li; Fangfang Jiang; Kaishuang Cai; Guangxue Ren
Journal:  Iran J Public Health       Date:  2019-04       Impact factor: 1.429

4.  Circulating Tumor Cells as a Screening and Diagnostic Marker for Early-Stage Non-Small Cell Lung Cancer.

Authors:  Guo-Chen Duan; Xiao-Peng Zhang; Hui-En Wang; Zhi-Kang Wang; Hua Zhang; Lei Yu; Wen-Fei Xue; Zhi-Fei Xin; Zhong-Hui Hu; Qing-Tao Zhao
Journal:  Onco Targets Ther       Date:  2020-03-04       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.